Research in Spain, and specially in Catalonia was improving, mainly due to budget increases, during last decade. But then the crisis came and science, regarded as a luxury and not as a necessity, suffered severe cuts. Oh short sighted politicians! Shame on you! These drastic changes raised alarms even in Nature, where a tough editorial against the measures was written.
During last ICCS I had the chance to meet other catalan chemoinformaticians that are performing exciting research, in the motherland and abroad. Frankly, it gave me some hope to see these young talents, carrying on with their work amidst the gloomy present and future for scientists in our country. Hopefully one day the muscles that will move the Catalan and Spanish economies will be our brains and not the arms that pile bricks and cement.
A picture was taken of the catalans at ICCS. Let’s see how many of us come to next edition.
From left to right
Xavi Jalencas, Oral Presentation, A knowledge-based approach to assessing the target promiscuity of chemical fragments. Xavi is a PhD student at the ChemogenomicsLab headed by Jordi Mestres, in Barcelona, Catalonia, Spain.
Violeta I. Perez-Nueno, Oral Presentation, Identifying and quantifying drug promiscuity by correlating ligand and target shape similarities. Violeta is a post-doc at LORIA, INRIA Nancy Grand Est, Vandoeuvre-les-Nancy, France.
Julio E. Peironcely, Oral Presentation, Improving metabolite identification with chemoinformatics. I am a PhD student at Leiden University , TNO and the Netherlands Metabolomics Centre.
Laura Guasch, Poster Presentation, Key features for designing PPARgamma agonists: an analysis of ligandreceptor interaction by using a 3D-QSAR approach. Laura is as well a PhD student at the Nutrigenomics group of Rovira i Virgili University, Tarragona, Catalonia, Spain.
Miguel Rojas-Cherto, Poster Presentation, Effectiveness of fingerprint-based measures of multi-stage mass spectrometry similarity for virtual screening of chemical structures. Miguel is a fellow post-doc at Leiden University and the Netherlands Metabolomics Centre.
Not in the picture we have Jordi Muñoz-Muriedas, Poster Presentation, Ames toxicity: strategies to remove ames liability for anilines. Jordi is a scientist at Glaxo Smithkline, Stevenage, United Kingdom.Interested in becoming a Scientist 2.0? Then visit my blog